File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: How We Design Feasibility Studies

TitleHow We Design Feasibility Studies
Authors
Bowen, DJKreuter, MSpring, BCoftaWoerpel, LLinnan, LWeiner, DBakken, SKaplan, CPSquiers, LFabrizio, CFernandez, M
Issue Date2009
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/amepre
Citation
American Journal Of Preventive Medicine, 2009, v. 36 n. 5, p. 452-457 How to Cite?
DOI: http://dx.doi.org/10.1016/j.amepre.2009.02.002
AbstractAbstract: Public health is moving toward the goal of implementing evidence-based interventions. To accomplish this, there is a need to select, adapt, and evaluate intervention studies. Such selection relies, in part, on making judgments about the feasibility of possible interventions and determining whether comprehensive and multilevel evaluations are justified. There exist few published standards and guides to aid these judgments. This article describes the diverse types of feasibility studies conducted in the field of cancer prevention, using a group of recently funded grants from the National Cancer Institute. The grants were submitted in response to a request for applications proposing research to identify feasible interventions for increasing the utilization of the Cancer Information Service among underserved populations. © 2009 American Journal of Preventive Medicine.
Persistent Identifierhttp://hdl.handle.net/10722/151673
ISSN
0749-3797
2021 Impact Factor: 6.604
2020 SCImago Journal Rankings: 2.287
ISI Accession Number ID
WOS:000265315200013
Funding AgencyGrant Number
National Cancer Institute1R21CA126325-01
1R21CA126990-01
1R21CA126326-01
1R21CA126373-01
1R21CA126450-01
1R21CA126321-01
Funding Information:

The projects described were supported by the following six grants from the National Cancer Institute: 1R21CA126325-01, 1R21CA126990-01, 1R21CA126326-01, 1R21CA126373-01, 1R21CA126450-01, and 1R21CA126321-01. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorBowen, DJen_US
dc.contributor.authorKreuter, Men_US
dc.contributor.authorSpring, Ben_US
dc.contributor.authorCoftaWoerpel, Len_US
dc.contributor.authorLinnan, Len_US
dc.contributor.authorWeiner, Den_US
dc.contributor.authorBakken, Sen_US
dc.contributor.authorKaplan, CPen_US
dc.contributor.authorSquiers, Len_US
dc.contributor.authorFabrizio, Cen_US
dc.contributor.authorFernandez, Men_US
dc.date.accessioned2012-06-26T06:26:22Z-
dc.date.available2012-06-26T06:26:22Z-
dc.date.issued2009en_US
dc.identifier.citationAmerican Journal Of Preventive Medicine, 2009, v. 36 n. 5, p. 452-457en_US
dc.identifier.issn0749-3797en_US
dc.identifier.urihttp://hdl.handle.net/10722/151673-
dc.description.abstractAbstract: Public health is moving toward the goal of implementing evidence-based interventions. To accomplish this, there is a need to select, adapt, and evaluate intervention studies. Such selection relies, in part, on making judgments about the feasibility of possible interventions and determining whether comprehensive and multilevel evaluations are justified. There exist few published standards and guides to aid these judgments. This article describes the diverse types of feasibility studies conducted in the field of cancer prevention, using a group of recently funded grants from the National Cancer Institute. The grants were submitted in response to a request for applications proposing research to identify feasible interventions for increasing the utilization of the Cancer Information Service among underserved populations. © 2009 American Journal of Preventive Medicine.en_US
dc.languageengen_US
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/amepreen_US
dc.relation.ispartofAmerican Journal of Preventive Medicineen_US
dc.subject.meshFeasibility Studiesen_US
dc.subject.meshFinancing, Governmenten_US
dc.subject.meshHumansen_US
dc.subject.meshMedically Underserved Areaen_US
dc.subject.meshNational Cancer Institute (U.S.)en_US
dc.subject.meshNeoplasms - Prevention & Controlen_US
dc.subject.meshPreventive Medicineen_US
dc.subject.meshPublic Healthen_US
dc.subject.meshResearch Designen_US
dc.subject.meshResearch Support As Topicen_US
dc.subject.meshUnited Statesen_US
dc.titleHow We Design Feasibility Studiesen_US
dc.typeArticleen_US
dc.identifier.emailFabrizio, C:fabrizio@hku.hken_US
dc.identifier.authorityFabrizio, C=rp00538en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.amepre.2009.02.002en_US
dc.identifier.pmid19362699-
dc.identifier.scopuseid_2-s2.0-64049116783en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-64049116783&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume36en_US
dc.identifier.issue5en_US
dc.identifier.spage452en_US
dc.identifier.epage457en_US
dc.identifier.isiWOS:000265315200013-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridBowen, DJ=7201884815en_US
dc.identifier.scopusauthoridKreuter, M=7006461100en_US
dc.identifier.scopusauthoridSpring, B=7005422536en_US
dc.identifier.scopusauthoridCoftaWoerpel, L=12344757400en_US
dc.identifier.scopusauthoridLinnan, L=7004352586en_US
dc.identifier.scopusauthoridWeiner, D=35286113800en_US
dc.identifier.scopusauthoridBakken, S=7005058463en_US
dc.identifier.scopusauthoridKaplan, CP=35994014000en_US
dc.identifier.scopusauthoridSquiers, L=10840758800en_US
dc.identifier.scopusauthoridFabrizio, C=6507289610en_US
dc.identifier.scopusauthoridFernandez, M=34769828800en_US
dc.identifier.citeulike4771343-
dc.identifier.issnl0749-3797-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats